In the quest to understand the origins and characteristics of COVID-19, several intriguing connections have emerged, linking snake venom, genetic sequences, and cutting-edge medical research. This article delves into the fascinating discoveries that shed light on these connections, challenging conventional wisdom and raising thought-provoking questions.
The Genetic Sequences: Snakes, Antibodies, and COVID-19:
Genetic sequencing of antibodies in COVID-19 patients yielded surprising results: the genetic sequences were not most similar to bats, but rather to two species of snakes—the Chinese crate and the king cobra. Researchers uncovered proteins from these snakes, suggesting a potential relationship between snake venom and COVID-19.
Nicotinic Acetyl Cholinesterase Receptors and Snake Venom:
Further research conducted in France in April 2020 revealed a fascinating connection between nicotinic acetylcholinesterase receptors in the brain and snake venom. The study found that these receptors bind tightly to snake venom, specifically from the crate and king cobra. Remarkably, the spike protein of SARS-CoV-2, the virus responsible for COVID-19, shares significant similarities with the venom from these snakes.
The Tragic Loss of Bing Liu and the University of Pittsburgh:
The article takes an unexpected turn when it mentions the tragic death of Bing Liu, a researcher at the University of Pittsburgh, who was on the verge of significant findings on COVID-19. This incident raises questions about the subsequent delay in publishing the work completed in his department. Interviews with Bing Liu's boss, Bahar, suggest that they intended to publish the findings but faced unforeseen obstacles.
The Hydroxychloroquine Connection:
A study published in January 2020 revealed a striking correlation between hydroxychloroquine, snake venom, and COVID-19. The study focused on mapping the genes of venom, proteins, and peptides in king cobra venom. Surprisingly, the funding for this study came from Genentech, a subsidiary of Roche, a pharmaceutical company. This finding triggers curiosity about a potential link between Genentech, Gilead (the manufacturer of Remdesivir), and the research surrounding COVID-19.
Lyophilized Powder and Snake Venom:
The article highlights the similarity between the appearance of lyophilized powder, the form in which Remdesivir is delivered to hospitals, and the color of stored snake venom. This intriguing parallel raises questions about the substances being administered to COVID-19 patients and their potential connection to snake venom.
Rattlesnake Venom and COVID-19 Deaths:
The research conducted by the University of Arizona demonstrates an intriguing discovery regarding the enzyme found in rattlesnake venom and its relation to COVID-19 deaths. By analyzing blood samples from COVID-19 patients, distinct patterns emerged, indicating that this enzyme played a role in attacking vital organs, leading to multiple organ failure and death.
Snake Venom and mRNA Vaccines:
The article explores the fascinating world of mRNA vaccines and their connection to snake venom. It highlights the research conducted by a Moderna co-founder, who aims to utilize mRNA technology to treat venomous snake bites. This endeavor led to the creation of Ophir Rex, a company focused on developing anti-venom drugs for snake bites, with funding from the Department of Defense, the Welcome Trust Fund, and the United Nations.
Conclusion:
The intertwining discoveries discussed in this article offer a captivating perspective on the origins and potential connections between snake venom, COVID-19, and medical research. While more investigation is needed to establish conclusive links, these findings ignite curiosity and encourage further exploration into the intricate world of viral diseases, genetic sequencing, and innovative medical advancements.